Jpmorgan Chase & CO Immunity Bio, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,183,416 shares of IBRX stock, worth $6.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,183,416

Previous 1,435,746 17.57%

Holding current value

$6.15 Million

Previous $7.71 Million 2.98%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.82 - $9.15 $1.22 Million - $2.31 Million	-252,330 Reduced 17.57%	1,183,416 $7.48 Million
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $43,714 - $83,504	13,534 Added 0.95%	1,435,746 $7.71 Million
Q4 2023 Feb 12, 2024	SELL	$1.25 - $5.21 $32,775 - $136,606	-26,220 Reduced 1.81%	1,422,212 $7.14 Million
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $39,372 - $94,615	-30,521 Reduced 2.06%	1,448,432 $2.45 Million
Q2 2023 Aug 11, 2023	SELL	$1.53 - $6.41 $205,546 - $861,145	-134,344 Reduced 8.33%	1,478,953 $4.11 Million
Q1 2023 May 18, 2023	BUY	$1.35 - $4.78 $153,009 - $541,765	113,340 Added 7.56%	1,613,297 $2.94 Million
Q1 2023 May 11, 2023	SELL	$1.35 - $4.78 $44,779 - $158,552	-33,170 Reduced 2.16%	1,499,957 $2.73 Million
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.77 $131,091 - $204,020	-30,136 Reduced 1.93%	1,533,127 $7.77 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $1.46 Million - $2.58 Million	401,369 Added 34.54%	1,563,263 $7.77 Million
Q2 2022 Aug 11, 2022	SELL	$2.68 - $6.14 $73,080 - $167,431	-27,269 Reduced 2.29%	1,161,894 $4.32 Million
Q1 2022 May 11, 2022	SELL	$5.05 - $7.53 $414,246 - $617,678	-82,029 Reduced 6.45%	1,189,163 $6.67 Million
Q4 2021 Feb 10, 2022	BUY	$5.67 - $10.18 $430,256 - $772,488	75,883 Added 6.35%	1,271,192 $7.73 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $11 Million - $17 Million	1,195,309 New	1,195,309 $11.6 Million

Others Institutions Holding IBRX

# of Institutions

215

Shares Held

63.3M

Call Options Held

1.44M

Put Options Held

4.12M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $2.08B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Immunity Bio, Inc. Transaction History